Cancer Therapy
Tissue Engineering has evoked new hopes for the cure of failure of Organs and loss tissue by creating functional substitutes in laboratory. TE provides new technology platforms to study the mechanism of angiogenesis and tumour cell growth and potentially tumour spreading in cancer research. The synthesis of TE with innovative methods of molecular biology and stem-cell technology may help investigate and potentially modulate principal phenomena of tumour growth and spreading, as well as tumour-related angiogenesis. TE can be applied to cure the cancer in Breast, Skin, Melanoma, Bone, Prostate, Liver and brain.
- Types of TE platforms for cancer research
- Breast cancer therapy
- Skin cancer therapy
- Endothelial cells and endothelial progenitor cells
- Tumour cell interactions with bone
- Liver and brain cancer therapy
- Drug delivery with TE techniques
- Newly detected cell types with potential for TE and cancer research
Related Conference of Cancer Therapy
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
Cancer Therapy Conference Speakers
Recommended Sessions
- Anti Aging, Rejuvenation & Replacement
- Applications of Stem cell in Regeneration
- Biobanking
- Biological Tissue Substitute
- Cancer Therapy
- Embryonic Development & Regeneration
- Genetic Modifications of Cells and Tissue
- Nanotechnology in Tissue Engineering
- Regeneration and Rehabilitation
- Regenerative Therapy & stem cell therapy
- Tissue culture and Preservation
- Tissue Engineering & Bioengineering
- Tissue Repair and Regeneration
- Translational & Regenerative Medicine
- Translational Stem cell research
Related Journals
Are you interested in
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)